Aspire Biopharma Holdings, Inc.
Aspire Biopharma develops a patent-pending delivery technology platform applicable to small and large molecule therapeutics, nutraceuticals, and supplements.
SCHEDULE 13G/ANov 16Latest SEC filing
Oct 21Latest story
Aspire Biopharma develops a patent-pending delivery technology platform applicable to small and large molecule therapeutics, nutraceuticals, and supplements.